A form of inherited hyperferritinemia associated with bi-allelic pathogenic variants of STAB1.


Journal

American journal of human genetics
ISSN: 1537-6605
Titre abrégé: Am J Hum Genet
Pays: United States
ID NLM: 0370475

Informations de publication

Date de publication:
03 08 2023
Historique:
received: 14 02 2023
revised: 29 06 2023
accepted: 06 07 2023
pmc-release: 03 02 2024
medline: 7 8 2023
pubmed: 26 7 2023
entrez: 25 7 2023
Statut: ppublish

Résumé

Hyperferritinemia is a frequent finding in several conditions, both genetic and acquired. We previously studied eleven healthy subjects from eight different families presenting with unexplained hyperferritinemia. Their findings suggested the existence of an autosomal-recessive disorder. We carried out whole-exome sequencing to detect the genetic cause of hyperferritinemia. Immunohistochemistry and flow cytometry assays were performed on liver biopsies and monocyte-macrophages to confirm the pathogenic role of the identified candidate variants. Through a combined approach of whole-exome sequencing and homozygosity mapping, we found bi-allelic STAB1 variants in ten subjects from seven families. STAB1 encodes the multifunctional scavenger receptor stabilin-1. Immunohistochemistry and flow cytometry analyses showed absent or markedly reduced stabilin-1 in liver samples, monocytes, and monocyte-derived macrophages. Our findings show a strong association between otherwise unexplained hyperferritinemia and bi-allelic STAB1 mutations suggesting the existence of another genetic cause of hyperferritinemia without iron overload and an unexpected function of stabilin-1 in ferritin metabolism.

Identifiants

pubmed: 37490907
pii: S0002-9297(23)00245-8
doi: 10.1016/j.ajhg.2023.07.004
pmc: PMC10432174
pii:
doi:

Substances chimiques

Ferritins 9007-73-2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1436-1443

Informations de copyright

Copyright © 2023 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing financial interests.

Références

Hepatol Commun. 2022 Jul;6(7):1611-1619
pubmed: 35271763
Blood. 2018 Jan 18;131(3):342-352
pubmed: 29074498
Haematologica. 2009 Mar;94(3):307-9
pubmed: 19252171
Front Physiol. 2020 Jul 21;11:873
pubmed: 32848838
Am J Gastroenterol. 2005 May;100(5):1185-94
pubmed: 15842597
Annu Rev Nutr. 2008;28:197-213
pubmed: 18489257
Scand J Gastroenterol. 2015 Apr;50(4):429-38
pubmed: 25633726
Biochem J. 1976 Jul 1;157(1):97-103
pubmed: 962866
Nat Methods. 2010 Apr;7(4):248-9
pubmed: 20354512
Immunobiology. 2009;214(7):576-93
pubmed: 19457577
Biomolecules. 2019 Jul 11;9(7):
pubmed: 31336723
Genome Med. 2021 Feb 22;13(1):31
pubmed: 33618777
J Biol Chem. 2020 Nov 13;295(46):15727-15741
pubmed: 32907880
Clin Cancer Res. 2019 Jun 1;25(11):3289-3303
pubmed: 30755440
Commun Biol. 2021 Feb 3;4(1):156
pubmed: 33536631
Front Physiol. 2021 Oct 11;12:757469
pubmed: 34707514
Am J Hematol. 2017 Apr;92(4):338-343
pubmed: 28052375
Biochim Biophys Acta. 2010 Aug;1800(8):760-9
pubmed: 20304033
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
Blood. 2002 May 15;99(10):3505-16
pubmed: 11986201
J Immunol. 2011 Apr 1;186(7):4147-55
pubmed: 21368224
N Engl J Med. 1975 May 1;292(18):951-6
pubmed: 1090831
Biometals. 2016 Feb;29(1):15-24
pubmed: 26612741
Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3505-10
pubmed: 20133674
Metallomics. 2014 Apr;6(4):748-73
pubmed: 24549403
J Clin Invest. 2011 Feb;121(2):703-14
pubmed: 21293057
ScientificWorldJournal. 2010 Oct 12;10:2039-53
pubmed: 20953554
Bioinformatics. 2015 Mar 1;31(5):761-3
pubmed: 25338716
Genome Res. 2001 May;11(5):863-74
pubmed: 11337480
Nat Methods. 2014 Apr;11(4):361-2
pubmed: 24681721
Blood. 2010 Sep 2;116(9):1574-84
pubmed: 20472835
Semin Liver Dis. 2022 Feb;42(1):61-76
pubmed: 34553345
Clin Cancer Res. 2021 Aug 1;27(15):4205-4220
pubmed: 34078651
J Neurochem. 2008 Dec;107(6):1495-505
pubmed: 19014383
Blood. 2004 Mar 15;103(6):2369-76
pubmed: 14615366
Nat Commun. 2021 Jan 22;12(1):518
pubmed: 33483490
Presse Med. 2017 Dec;46(12 Pt 2):e329-e338
pubmed: 29150231
Eur J Immunol. 2003 Mar;33(3):815-24
pubmed: 12616502
Dev Cell. 2009 Jan;16(1):35-46
pubmed: 19154717
Inorg Chem. 2013 Nov 4;52(21):12223-33
pubmed: 24102308

Auteurs

Edoardo Monfrini (E)

Dino Ferrari Center, Department of Pathophysiology and Transplantation, University of Milano, Milano, Italy; Foundation IRCCS Cà Granda Ospedale Maggiore Policlinico, Neurology Unit, Milano, Italy.

Sara Pelucchi (S)

School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.

Maija Hollmén (M)

MediCity Research Laboratory and InFLAMES flagship, University of Turku, Turku, Finland.

Miro Viitala (M)

MediCity Research Laboratory and InFLAMES flagship, University of Turku, Turku, Finland.

Raffaella Mariani (R)

Centre for Rare Disease - Disorders of Iron Metabolism, Fondazione IRCCS, San Gerardo dei Tintori, European Reference Network - EuroBloodNet, Monza, Italy.

Francesca Bertola (F)

Cytogenetics and Medical Genetics, Fondazione IRCCS, San Gerardo dei Tintori, Monza, Italy.

Silvia Majore (S)

Medical Genetics, Department of Molecular Medicine, Sapienza University, San Camillo-Forlanini Hospital, Roma, Italy.

Alessio Di Fonzo (A)

Foundation IRCCS Cà Granda Ospedale Maggiore Policlinico, Neurology Unit, Milano, Italy.

Alberto Piperno (A)

Centre for Rare Disease - Disorders of Iron Metabolism, Fondazione IRCCS, San Gerardo dei Tintori, European Reference Network - EuroBloodNet, Monza, Italy; Centro Ricerca Tettamanti, Monza, Italy. Electronic address: alberto.piperno@unimib.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH